4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-21-069423
Chief Operating Officer acquired 40,315 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| HIGH SUSANNA GATTI Chief Operating Officer | 2021-12-10 | Grant or award | +40,315 | 73,768 | D | ||
| Derivatives | |||||||
| HIGH SUSANNA GATTI Chief Operating Officer | 2021-12-10 | Grant or award · Stock Option (right to buy) | +60,472 | 60,472 | D | ||
Loading xslF345X03/doc4.xml…